Integrin alpha 3 beta 1 participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells

• Published in: Molecular biology of the cell Vol. 7; no. 11; pp. 1789 - 1804
• Main Authors: Coopman, P J, Thomas, D M, Gehlsen, K R, Mueller, S C
• Format: Journal Article
• Language: English
• Published: United States 01.11.1996
• Subjects: Amino Acid Sequence; Antibodies, Monoclonal; Antigens, CD - immunology; Breast Neoplasms - physiopathology; Cell Membrane - chemistry; Extracellular Matrix - metabolism; Gelatin - metabolism; Humans; Integrin alpha2; Integrin alpha3; Integrin alpha3beta1; Integrins - analysis; Integrins - immunology; Integrins - metabolism; Integrins - physiology; Laminin - metabolism; Laminin - pharmacology; Molecular Sequence Data; Peptide Fragments - pharmacology; Phagocytosis; Receptors, Laminin - analysis; Receptors, Laminin - metabolism; Receptors, Laminin - physiology; Signal Transduction; Tumor Cells, Cultured
• ISSN: 1059-1524; 1939-4586
• DOI: 10.1091/mbc.7.11.1789

The mechanisms and receptors involved in phagocytosis by nonhematopoietic cells are not well understood. The involvement of the alpha 3 beta 1 integrin in phagocytosis of the extracellular matrix by human breast cancer cells was studied. The possible role of this integrin was suggested since alpha 3 and beta 1 but not alpha 2 subunits are concentrated at membrane sites where local degradation of fluorescently labeled gelatin occurs. Strikingly, anti-alpha 3 integrin monoclonal antibodies (mAbs) stimulate the phagocytosis of fluorescently labeled gelatin films, gelatin beads, and Matrigel films in a quantitative phagocytosis assay. Stimulation of the gelatin uptake by the anti-alpha 3 mAb is dose responsive, saturable, and time dependent. Antibodies against other integrin subunits have a lower stimulatory effect (anti-beta 1) or no significant effect (anti-alpha 2, -alpha 5, -alpha 6, and -alpha v) on gelatin phagocytosis. The synthetic HGD-6 human laminin peptide that binds specifically the alpha 3 beta 1 integrin, but not the scrambled HSGD-6 control peptide, also markedly stimulates gelatin uptake in a dose-responsive way. Furthermore, the stimulatory effects of the HGD-6 peptide and the anti-alpha 3 mAb are additive, suggesting that they might promote phagocytosis in different ways. Other laminin (YIGSR, IKVAV) and fibronectin (GRGDS) peptides have no effect on gelatin phagocytosis. Immunofluorescence shows that the alpha 3 and the beta 1, but not the alpha 2 integrin subunit, concentrate into patches on the cell surface after treatment with their respective mAbs. And, both gelatin and the alpha 3 beta 1 but not the alpha 2 beta 1 integrin are cointernalized and routed to acidic vesicles such as lysosomes. In conclusion, we demonstrate that human breast cancer cells locally degrade and phagocytose the extracellular matrix and show for the first time that the alpha 3 beta 1 integrin participates in this phagocytosis. We hypothesize that the anti-alpha 3 antibodies and the laminin peptide HGD-6 activate the alpha 3 beta 1 integrin, which results in a downstream signaling cascade stimulating phagocytosis.